BFB Health (HKSE:00205) Research & Development: HK$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00205 BFB Health Ltd HKSE:00205
36 GF Score
Price HK$0.55
GF Value HK$0.14
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is BFB Health Research & Development?

BFB Health HKSE:00205 36 Research & Development is HK$0.00 Mil as of Dec. 2025. GuruFocus rates HKSE:00205 with a GF Score™ of 36/100 and a GF Value™ of HK$0.14 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BFB Health's Research & Development for the six months ended in Dec. 2025 was HK$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.00 Mil.

BFB Health  (HKSE:00205) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BFB Health Research & Development Related Terms

BFB Health Research & Development Historical Data

* Premium members only.

The historical data trend for BFB Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BFB Health Research & Development Chart

BFB Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BFB Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:00205
36GF Score
BFB Health Ltd HKSE:00205
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BFB Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.00 Mil mean?
BFB Health (HKSE:00205) has a Research & Development of HK$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BFB Health and its competitors.
Is BFB Health's Research & Development too high?
BFB Health's current Research & Development is HK$0.00 Mil. Overall, BFB Health has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BFB Health's Research & Development compare to APP and OMC?
BFB Health's Research & Development of HK$0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BFB Health and its competitors. BFB Health's current Research & Development is HK$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BFB Health stock overvalued right now?
Based on GuruFocus' analysis, BFB Health (HKSE:00205) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.55 — trading 292.9% above its estimated fair value. The current Research & Development is HK$0.00 Mil. BFB Health's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BFB Health (HKSE:00205), the current Research & Development is HK$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BFB Health (HKSE:00205) Overvalued in 2026?

Based on GuruFocus' analysis, BFB Health stock appears to be overvalued. The current stock price of HK$0.55 is trading 292.9% above its estimated GF Value™ of HK$0.14. GuruFocus considers BFB Health to be Significantly Overvalued.

Key valuation signals for HKSE:00205:

  • Research & Development: HK$0.00 Mil
  • GF Value™: HK$0.14 vs. price of HK$0.55 (292.9% above fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BFB Health Business Description

Address 99 Queen’s Road Central, Room 2301, 23rd Floor, The Center, Sheung Wan, Hong Kong, HKG
BFB Health Ltd is an investment holding company. Along with its subsidiaries, it operates in the following reportable segments: Provision of advertising and e-commerce business, Provision of securities broking services, and Money lending. Maximum revenue is derived from the Provision of advertising and e-commerce business, which generates the majority of its revenue from the sales of health and wellness products, through e-commerce channels, and the rest comes from the provision of advertising services, sales of books and magazines, and multi-channel network activities. Geographically, the Group generates maximum revenue from the People's Republic of China (PRC), and the rest from Hong Kong.
36GF Score

Get the complete analysis for HKSE:00205

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.55
Price
HK$0.14
GF Value